Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10591418rdf:typepubmed:Citationlld:pubmed
pubmed-article:10591418lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:10591418lifeskim:mentionsumls-concept:C0205653lld:lifeskim
pubmed-article:10591418lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:10591418lifeskim:mentionsumls-concept:C0011854lld:lifeskim
pubmed-article:10591418lifeskim:mentionsumls-concept:C1705413lld:lifeskim
pubmed-article:10591418lifeskim:mentionsumls-concept:C1522326lld:lifeskim
pubmed-article:10591418pubmed:issue11lld:pubmed
pubmed-article:10591418pubmed:dateCreated2000-1-6lld:pubmed
pubmed-article:10591418pubmed:abstractTextThe main objective of this study was to examine the relation between adverse events and degree of metabolic control and multiple-dose treatment. A total of 139 children, aged between 1 and 18 y, prospectively registered severe hypoglycaemia with or without unconsciousness, as well as hospitalized ketoacidosis, during 1994-95. Treatment from onset was multiple-dose insulin (> 95% > or = 4 doses) combined with intense training and psychosocial support. Median HbA1c was 6.9% (ref. 3.6-5.4%). The incidence of severe hypoglycaemia with unconsciousness was 0.17 events per patient-year, having decreased from the 1970s to the 1990s, parallel to a change from 1-2 to > or = 4 doses per day. There was no correlation or association to the year mean HbA1c for severe hypoglycaemia. Severe hypoglycaemic episodes in 1995 correlated to severe hypoglycaemic episodes in 1994 (r=0.38; p<0.0001). Severe hypoglycaemia with unconsciousness increased during the spring season, and according to case records the assumed causes were mainly mistakes with insulin, food and exercise. Ketoacidosis was rare: 0.015 episodes per patient-year. We conclude that multiple-dose insulin therapy from the very onset of diabetes, combined with adequate self-control, active problem-based training and psycho-social support, may limit severe hypoglycaemia and ketoacidosis. Strategies aimed at minimizing severe hypoglycaemia without compromising metabolic control need to be evaluated.lld:pubmed
pubmed-article:10591418pubmed:languageenglld:pubmed
pubmed-article:10591418pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10591418pubmed:citationSubsetIMlld:pubmed
pubmed-article:10591418pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10591418pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10591418pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10591418pubmed:statusMEDLINElld:pubmed
pubmed-article:10591418pubmed:monthNovlld:pubmed
pubmed-article:10591418pubmed:issn0803-5253lld:pubmed
pubmed-article:10591418pubmed:authorpubmed-author:LudvigssonJJlld:pubmed
pubmed-article:10591418pubmed:authorpubmed-author:NordfeldtSSlld:pubmed
pubmed-article:10591418pubmed:issnTypePrintlld:pubmed
pubmed-article:10591418pubmed:volume88lld:pubmed
pubmed-article:10591418pubmed:ownerNLMlld:pubmed
pubmed-article:10591418pubmed:authorsCompleteYlld:pubmed
pubmed-article:10591418pubmed:pagination1184-93lld:pubmed
pubmed-article:10591418pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:10591418pubmed:meshHeadingpubmed-meshheading:10591418...lld:pubmed
pubmed-article:10591418pubmed:meshHeadingpubmed-meshheading:10591418...lld:pubmed
pubmed-article:10591418pubmed:meshHeadingpubmed-meshheading:10591418...lld:pubmed
pubmed-article:10591418pubmed:meshHeadingpubmed-meshheading:10591418...lld:pubmed
pubmed-article:10591418pubmed:meshHeadingpubmed-meshheading:10591418...lld:pubmed
pubmed-article:10591418pubmed:meshHeadingpubmed-meshheading:10591418...lld:pubmed
pubmed-article:10591418pubmed:meshHeadingpubmed-meshheading:10591418...lld:pubmed
pubmed-article:10591418pubmed:meshHeadingpubmed-meshheading:10591418...lld:pubmed
pubmed-article:10591418pubmed:meshHeadingpubmed-meshheading:10591418...lld:pubmed
pubmed-article:10591418pubmed:meshHeadingpubmed-meshheading:10591418...lld:pubmed
pubmed-article:10591418pubmed:meshHeadingpubmed-meshheading:10591418...lld:pubmed
pubmed-article:10591418pubmed:meshHeadingpubmed-meshheading:10591418...lld:pubmed
pubmed-article:10591418pubmed:meshHeadingpubmed-meshheading:10591418...lld:pubmed
pubmed-article:10591418pubmed:meshHeadingpubmed-meshheading:10591418...lld:pubmed
pubmed-article:10591418pubmed:meshHeadingpubmed-meshheading:10591418...lld:pubmed
pubmed-article:10591418pubmed:meshHeadingpubmed-meshheading:10591418...lld:pubmed
pubmed-article:10591418pubmed:meshHeadingpubmed-meshheading:10591418...lld:pubmed
pubmed-article:10591418pubmed:meshHeadingpubmed-meshheading:10591418...lld:pubmed
pubmed-article:10591418pubmed:meshHeadingpubmed-meshheading:10591418...lld:pubmed
pubmed-article:10591418pubmed:meshHeadingpubmed-meshheading:10591418...lld:pubmed
pubmed-article:10591418pubmed:meshHeadingpubmed-meshheading:10591418...lld:pubmed
pubmed-article:10591418pubmed:meshHeadingpubmed-meshheading:10591418...lld:pubmed
pubmed-article:10591418pubmed:meshHeadingpubmed-meshheading:10591418...lld:pubmed
pubmed-article:10591418pubmed:year1999lld:pubmed
pubmed-article:10591418pubmed:articleTitleAdverse events in intensively treated children and adolescents with type 1 diabetes.lld:pubmed
pubmed-article:10591418pubmed:affiliationDepartment of Health and Environment, Faculty of Health Sciences, Linköping, Sweden.lld:pubmed
pubmed-article:10591418pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10591418pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:10591418pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10591418lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10591418lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10591418lld:pubmed